Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Rhesus rotavirus vaccine effectiveness and factors associated with receipt of vaccine.

Staat MA, Cortese MM, Bresee JS, Bégué RE, Vitek C, Rhodes P, Zhang R, Gentsch J, Roberts NE, Jaeger JL, Ward R, Bernstein DI, Dennehy PH.

Pediatr Infect Dis J. 2006 Nov;25(11):1013-8.

PMID:
17072123
2.

Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study.

Fu C, Wang M, Liang J, He T, Wang D, Xu J.

Vaccine. 2007 Dec 17;25(52):8756-61. Epub 2007 Nov 5.

PMID:
18023510
3.

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.

Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD.

Pediatrics. 2010 Feb;125(2):e199-207. doi: 10.1542/peds.2009-1021. Epub 2010 Jan 18.

PMID:
20083525
4.

Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine.

Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, Patel MM, Baggs JM, Parashar UD.

Pediatrics. 2009 Mar;123(3):744-9. doi: 10.1542/peds.2008-1200.

PMID:
19254997
5.

A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children.

Dennehy PH, Cortese MM, Bégué RE, Jaeger JL, Roberts NE, Zhang R, Rhodes P, Gentsch J, Ward R, Bernstein DI, Vitek C, Bresee JS, Staat MA.

Pediatr Infect Dis J. 2006 Dec;25(12):1123-31.

PMID:
17133157
6.

Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.

Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.

Pediatrics. 2010 Feb;125(2):e208-13. doi: 10.1542/peds.2009-1246. Epub 2010 Jan 25.

PMID:
20100757
7.

Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.

Muhsen K, Shulman L, Kasem E, Rubinstein U, Shachter J, Kremer A, Goren S, Zilberstein I, Chodick G, Ephros M, Cohen D.

Hum Vaccin. 2010 Jun;6(6):450-4. Epub 2010 Jun 1.

PMID:
20448471
8.

Effectiveness of pentavalent rotavirus vaccine against severe disease.

Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, Griffin MR, Hall CB, Curns AT, Gentsch JR, Salisbury S, Fairbrother G, Parashar UD; New Vaccine Surveillance Network (NVSN).

Pediatrics. 2011 Aug;128(2):e267-75. doi: 10.1542/peds.2010-3722. Epub 2011 Jul 18.

9.

Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.

Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Cardellino A, Sánchez E.

Pediatr Infect Dis J. 2011 Nov;30(11):e209-15. doi: 10.1097/INF.0b013e31822a8527.

PMID:
21768920
10.

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

J Infect Dis. 2006 Aug 1;194(3):370-6. Epub 2006 Jun 23.

11.

Evaluation of rotavirus vaccine effectiveness in a pediatric group practice.

Pérez Mato S, Perrin K, Scardino D, Bégué RE.

Am J Epidemiol. 2002 Dec 1;156(11):1049-55.

12.

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE.

Pediatr Infect Dis J. 2011 May;30(5):396-401. doi: 10.1097/INF.0b013e3182055cc2.

PMID:
21150692
13.

Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.

Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ; REST Study Team.

Pediatr Infect Dis J. 2007 Dec;26(12):1099-104.

PMID:
18043445
14.

Rotavirus vaccines and intussusception risk.

Bines JE.

Curr Opin Gastroenterol. 2005 Jan;21(1):20-5. Review.

PMID:
15687880
15.

Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine.

Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar UD, Immergluck LC.

Pediatrics. 2011 Dec;128(6):e1474-81. doi: 10.1542/peds.2011-1006. Epub 2011 Nov 14.

16.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group.

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
17.

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.

Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.

PMID:
19047240
18.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
19.

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.

Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434.

PMID:
19935446
20.

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

Vesikari T, Karvonen A, Puustinen L, Zeng SQ, Szakal ED, Delem A, De Vos B.

Pediatr Infect Dis J. 2004 Oct;23(10):937-43.

PMID:
15602194
Items per page

Supplemental Content

Write to the Help Desk